litlas
Log inCreate account

Frits van Rhee

Active 1994–2025

157
Papers
21,735
Citations
82
h-index
147
i10-index

Citations

Citations per year for Frits van Rhee1993: 4 citations1994: 2 citations1995: 8 citations1996: 6 citations1997: 16 citations1998: 15 citations1999: 42 citations2000: 50 citations2001: 32 citations2002: 55 citations2003: 80 citations2004: 54 citations2005: 63 citations2006: 73 citations2007: 149 citations2008: 136 citations2009: 203 citations2010: 171 citations2011: 208 citations2012: 187 citations2013: 160 citations2014: 172 citations2015: 158 citations2016: 139 citations2017: 206 citations2018: 170 citations2019: 545 citations2020: 585 citations2021: 649 citations2022: 515 citations2023: 319 citations2024: 691 citations2025: 328 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,900 citing papers, 28.6% of this breakdownChina: 472 citing papers, 7.1% of this breakdownGermany: 457 citing papers, 6.9% of this breakdownItaly: 428 citing papers, 6.5% of this breakdownUnited Kingdom: 418 citing papers, 6.3% of this breakdownFrance: 367 citing papers, 5.5% of this breakdownSpain: 298 citing papers, 4.5% of this breakdownNetherlands: 223 citing papers, 3.4% of this breakdownCanada: 189 citing papers, 2.8% of this breakdownJapan: 178 citing papers, 2.7% of this breakdownAustralia: 147 citing papers, 2.2% of this breakdownGreece: 138 citing papers, 2.1% of this breakdown
0%28.6%Other 21.4%

Institutions

Fields

  • Medicine76.7%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Immunology and Microbiology9.3%
  • Computer Science0.3%
  • Neuroscience0.2%
  • Agricultural and Biological Sciences0.2%
  • Other1%

Topics

  • Multiple Myeloma Research and Treatments16.3%
  • Protein Degradation and Inhibitors7.1%
  • CAR-T cell therapy research4.3%
  • Immune Cell Function and Interaction3.8%
  • Peptidase Inhibition and Analysis3.7%
  • Hematopoietic Stem Cell Transplantation2.6%
  • Other62.2%

Coauthors

All papers

Open in search
  1. Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

    Authors: Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Anita D’Souza, Anikó Szabó, Carolina Schinke, Rajshekhar Chakraborty - Blood Cancer Journal 2024 cited by 97

  2. The molecular classification of multiple myeloma

    Authors: Fenghuang Zhan, Yongsheng Huang, Simona Colla, Peter Stewart, Ichiro Hanamura, Sushil Gupta, Joshua Epstein, Shmuel Yaccoby, Jeffrey R. Sawyer, Bart Burington, Elias Anaissie, Klaus Hollmig, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie, John D. Shaughnessy - Blood 2006 cited by 1,142

  3. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    Authors: Leo Rasche, Shweta S. Chavan, Owen Stephens, Pragi Patel, Ruslana G. Tytarenko, Cody Ashby, Michael Bauer, Joshua Epstein, S Deshpande, Christopher P. Wardell, Tímea Buzder, Gábor Molnár, Maurizio Zangari, Frits van Rhee, Sharmilan Thanendrarajan, Carolina Schinke, Joshua Epstein, Faith E. Davies, Brian A. Walker, Tobias Meißner, Bart Barlogie, Gareth J. Morgan, Niels Weinhold - Nature Communications 2017 cited by 419

  4. International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    Authors: David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Dale Frank, David Wu, Gordan Srkalović, David Simpson, Amy Liu, David M. Menke, Shanmuganathan Chandrakasan, Mary Jo Lechowicz, Raymond Wong, Sheila K. Pierson, Michele Paessler, Jean‐François Rossi, Makoto Ide, Jason R. Ruth, M.P. Croglio, Alexander Suarez, Vera P. Krymskaya, Amy Chadburn, Gisele W. B. Colleoni, Sunita D. Nasta, Raj Jayanthan, Christopher S. Nabel, Corey Casper, Angela Dispenzieri, Alexander Fosså, Dermot Kelleher, Razelle Kurzrock, Peter M. Voorhees, Ahmet Doǧan, Kazuyuki Yoshizaki, Frits van Rhee, Éric Oksenhendler, Elaine S. Jaffe, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim - Blood 2017 cited by 624

  5. CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

    Authors: Eric D. Hsi, Roxanne Steinle, Balaji Balasa, Susann Szmania, Aparna Draksharapu, Benny P. Shum, Mahrukh Huseni, David B. Powers, Amulya Nanisetti, Yin Zhang, Audie Rice, Anne van Abbema, Melanie Wong, Gao Liu, Fenghuang Zhan, Myles Dillon, Shihao Chen, Susan Rhodes, Franklin Fuh, Naoya Tsurushita, Shankar Kumar, Vladimir Vexler, John D. Shaughnessy, Bart Barlogie, Frits van Rhee, Mohamad A. Hussein, Daniel Afar, Marna Williams - Clinical Cancer Research 2008 cited by 560

  6. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

    Authors: Saad Z. Usmani, Christoph Heuck, Alyson E. Mitchell, Jackie Szymonifka, Bijay Nair, Antje Hoering, Yazan Alsayed, Sarah Waheed, Sajjad Haider, Alejandro Restrepo, Frits van Rhee, John Crowley, Bart Barlogie - Haematologica 2012 cited by 389

  7. The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma

    Authors: Lindsay Hammons, Anikó Szabó, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Ravi Narra, Divaya Bhutani, Sharmilan Thanendrarajan, Siegfried Janz, Maurizio Zangari, Suzanne Lentzsch, Frits van Rhee, Juan Carlos Rico Crescencio, Anita D’Souza, Rajshekhar Chakraborty, Meera Mohan, Carolina Schinke - Haematologica 2023 cited by 50

  8. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

    Authors: Frits van Rhee, Peter M. Voorhees, Angela Dispenzieri, Alexander Fosså, Gordan Srkalović, Makoto Ide, Nikhil C. Munshi, Stephen Schey, Matthew Streetly, Sheila K. Pierson, Helen Partridge, Sudipto Mukherjee, Dustin Shilling, Katie Stone, Amy D Greenway, Jason R. Ruth, Mary Jo Lechowicz, Shanmuganathan Chandrakasan, Raj Jayanthan, Elaine S. Jaffe, Heather A. Leitch, Naveen Pemmaraju, Amy Chadburn, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson, Vera P. Krymskaya, Aaron M. Goodman, Christian Hoffmann, Pier Luigi Zinzani, Simone Ferrero, Louis Terriou, Yasuharu Sato, David Simpson, Raymond Wong, Jean‐François Rossi, Sunita D. Nasta, Kazuyuki Yoshizaki, Razelle Kurzrock, Thomas S. Uldrick, Corey Casper, Éric Oksenhendler, David C. Fajgenbaum - Blood 2018 cited by 414

  9. Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma

    Authors: Leo Rasche, Edgardo Angtuaco, James E. McDonald, Amy Buros, Caleb Stein, Charlotte Pawlyn, Sharmilan Thanendrarajan, Carolina Schinke, Rohan Samant, Shmuel Yaccoby, Brian A. Walker, Joshua Epstein, Maurizio Zangari, Frits van Rhee, Tobias Meißner, Hartmut Goldschmidt, Kari Hemminki, Richard S. Houlston, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Blood 2017 cited by 248

  10. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

    Authors: Eileen M. Boyle, Shayu Deshpande, Ruslana G. Tytarenko, Cody Ashby, Yan Wang, Michael Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Façon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker - Nature Communications 2021 cited by 138

  11. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    Authors: John D. Shaughnessy, Fenghuang Zhan, Bart Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, Peter Stewart, Bob Kordsmeier, Christopher E. Randolph, David R. Williams, Yan Xiao, Hongwei Xu, Joshua Epstein, Elias Anaissie, Somashekar G. Krishna, Michele Cottler‐Fox, Klaus Hollmig, Abid Mohiuddin, Mauricio Pineda‐Roman, Guido Tricot, Frits van Rhee, Jeffrey R. Sawyer, Yazan Alsayed, Ronald C. Walker, Maurizio Zangari, John Crowley, Bart Barlogie - Blood 2006 cited by 916

  12. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation

    Authors: Ichiro Hanamura, Peter Stewart, Yongsheng Huang, Fenghuang Zhan, Madhumita Santra, Jeffrey R. Sawyer, Klaus Hollmig, Maurizio Zangarri, Mauricio Pineda‐Roman, Frits van Rhee, Federica Cavallo, Bart Burington, John Crowley, Guido Tricot, Bart Barlogie, John D. Shaughnessy - Blood 2006 cited by 479

  13. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level

    Authors: Lukas John, Alexandra M. Poos, Alexander Brobeil, Carolina Schinke, Stefanie Huhn, Nina Prokoph, Raphael Lutz, Barbara Wagner, Maurizio Zangari, Stephan M. Tirier, Jan‐Philipp Mallm, Sabrina Schumacher, Dominik Vonficht, Llorenç Solé‐Boldo, Sabine Quick, Simon Steiger, Moritz J. Przybilla, Katharina Bauer, Anja Baumann, Stefan Hemmer, Christoph Rehnitz, Christian Lückerath, Christos Sachpekidis, Gunhild Mechtersheimer, Uwe Haberkorn, Antonia Dimitrakopoulou‐Strauss, Philipp Reichert, Bart Barlogie, Carsten Müller‐Tidow, Hartmut Goldschmidt, Jens Hillengaß, Leo Rasche, Simon Haas, Frits van Rhee, Karsten Rippe, Marc S. Raab, Sandra Sauer, Niels Weinhold - Nature Communications 2023 cited by 38

  14. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

    Authors: Frits van Rhee, Raymond Wong, Nikhil C. Munshi, Jean‐François Rossi, Xiaoyan Ke, Alexander Fosså, David Simpson, Marcelo Capra, Ting Liu, Ruey Kuen Hsieh, Yeow Tee Goh, Jun Zhu, Seok‐Goo Cho, Hanyun Ren, James Cavet, Rajesh Bandekar, Margaret Rothman, Thomas A. Puchalski, Manjula Reddy, Helgi van de Velde, Jessica Vermeulen, Corey Casper - The Lancet Oncology 2014 cited by 442

  15. The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

    Authors: Leo Rasche, Carolina Schinke, Francesco Maura, Michael Bauer, Cody Ashby, Shayu Deshpande, Alexandra M. Poos, Maurizio Zangari, Sharmilan Thanendrarajan, Faith E. Davies, Brian A. Walker, Bart Barlogie, Ola Landgren, Gareth J. Morgan, Frits van Rhee, Niels Weinhold - Nature Communications 2022 cited by 76

  16. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

    Authors: Twyla B. Bartel, Jeff Haessler, Tracy L. Brown, John D. Shaughnessy, Frits van Rhee, Elias Anaissie, Terri L. Alpe, Edgardo Angtuaco, Ronald C. Walker, Joshua Epstein, John Crowley, Bart Barlogie - Blood 2009 cited by 523

  17. Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients

    Authors: Susann Szmania, Natalia Lapteva, Tarun K. Garg, Amy D Greenway, Joshuah D Lingo, Bijay Nair, Katie L. Stone, Emily Woods, Junaid Khan, Justin Stivers, Susan Panozzo, Dario Campana, William Bellamy, Molly Robbins, Joshua Epstein, Shmuel Yaccoby, Sarah Waheed, Adrian P. Gee, Michele Cottler‐Fox, Cliona M. Rooney, Bart Barlogie, Frits van Rhee - Journal of Immunotherapy 2014 cited by 180

  18. Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

    Authors: Leo Rasche, Daisy Alapat, Manoj Kumar, Grant Gershner, James E. McDonald, Christopher P. Wardell, Rohini Samant, Rudy Van Hemert, Joshua Epstein, Anjana Williams, Sharmilan Thanendrarajan, Carolina Schinke, Michael Bauer, Cody Ashby, Ruslana G. Tytarenko, Frits van Rhee, Brian A. Walker, Maurizio Zangari, Bart Barlogie, Faith E. Davies, Gareth J. Morgan, Niels Weinhold - Leukemia 2018 cited by 152

  19. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease

    Authors: Yoshito Nishimura, David C. Fajgenbaum, Sheila K. Pierson, Noriko Iwaki, Asami Nishikori, Mitsuhiro Kawano, Naoya Nakamura, Koji Izutsu, Kengo Takeuchi, Midori Filiz Nishimura, Yoshinobu Maeda, Fumio Otsuka, Kazuyuki Yoshizaki, Éric Oksenhendler, Frits van Rhee, Yasuharu Sato - American Journal of Hematology 2021 cited by 125

  20. Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma

    Authors: Raghad Abdelqader Al-Qazaqi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Fenghuang Zhan, Guido Tricot, Frits van Rhee, Samer Al Hadidi - JAMA Network Open 2022 cited by 59

  21. Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level

    Authors: Carolina Schinke, Alexandra M. Poos, Michael Bauer, Lukas John, Sadie Johnson, Shayu Deshpande, Luis F. Carrillo, Daisy Alapat, Leo Rasche, Sharmilan Thanendrarajan, Maurizio Zangari, Samer Al Hadidi, Frits van Rhee, Faith E. Davies, Marc S. Raab, Gareth J. Morgan, Niels Weinhold - Blood Advances 2022 cited by 55

  22. Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

    Authors: David C. Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, Helen Partridge, Sheila K. Pierson, Amrit Singh, Daniel J. Arenas, Jason R. Ruth, Christopher S. Nabel, Katie Stone, Mariko Okumura, Anthony P. Schwarer, Fábio Freire José, Nelson Hamerschlak, Gerald Wertheim, Michael B. Jordan, Adam D. Cohen, Vera P. Krymskaya, Arthur H. Rubenstein, Michael R. Betts, Taku Kambayashi, Frits van Rhee, Thomas S. Uldrick - Journal of Clinical Investigation 2019 cited by 140

  23. Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth

    Authors: Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David E. Mery, Hongwei Xu, Dongzheng Gai, Eric R. Siegel, Clyde Bailey, Cody Ashby, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z. Orlowski, Maurizio Zangari, Frits van Rhee, Siegfried Janz, Gail A. Bishop, Guido Tricot, John D. Shaughnessy, Fenghuang Zhan - Nature Communications 2024 cited by 43

  24. Idiopathic multicentric Castleman's disease: a systematic literature review

    Authors: Amy Liu, Christopher S. Nabel, Brian S. Finkelman, Jason R. Ruth, Razelle Kurzrock, Frits van Rhee, Vera P. Krymskaya, Dermot Kelleher, Arthur H. Rubenstein, David C. Fajgenbaum - The Lancet Haematology 2016 cited by 324